Complement and IgM in FSGS: Minor Characters or Leading Actors?
作者信息
Angeletti Andrea, Cravedi Paolo
机构信息
Nephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York.
出版信息
Kidney360. 2025 Aug 28;6(8):1265-1267. doi: 10.34067/KID.0000000814.
Abstract
摘要
相似文献
1
Complement and IgM in FSGS: Minor Characters or Leading Actors?局灶节段性肾小球硬化中的补体和IgM：小角色还是主角？
Kidney360. 2025 Aug 28;6(8):1265-1267. doi: 10.34067/KID.0000000814.
2
The to be, or not to be, of acting autistic.表现出自闭行为的“存在与否”。
Autism. 2025 Mar;29(3):802-814. doi: 10.1177/13623613241290270. Epub 2024 Oct 29.
3
IgM as a novel predictor of disease progression in secondary focal segmental glomerulosclerosis.IgM作为继发性局灶节段性肾小球硬化疾病进展的新型预测指标。
Croat Med J. 2017 Aug 31;58(4):281-291. doi: 10.3325/cmj.2017.58.281.
4
Analysis of glomerular deposition of IgM and C3 in patients with podocytopathies.分析足细胞病患者肾小球 IgM 和 C3 的沉积。
Ann Diagn Pathol. 2024 Jun;70:152292. doi: 10.1016/j.anndiagpath.2024.152292. Epub 2024 Mar 7.
5
Complement activation profile of patients with primary focal segmental glomerulosclerosis.原发性局灶节段性肾小球硬化症患者的补体激活谱。
PLoS One. 2020 Jun 22;15(6):e0234934. doi: 10.1371/journal.pone.0234934. eCollection 2020.
6
Natural antibody and complement activation characterize patients with idiopathic nephrotic syndrome.天然抗体和补体激活可作为特发性肾病综合征的特征。
Am J Physiol Renal Physiol. 2021 Oct 1;321(4):F505-F516. doi: 10.1152/ajprenal.00041.2021. Epub 2021 Aug 30.
7
Anti-nephrin antibodies in adult Chinese patients with minimal change disease and primary focal segmental glomerulosclerosis.成年中国微小病变病和原发性局灶节段性肾小球硬化患者的抗肾足细胞蛋白抗体
Kidney Int. 2025 Mar 25. doi: 10.1016/j.kint.2025.02.028.
8
A single-chain antibody construct with specificity of a natural IgM antibody reduces hepatic ischemia reperfusion injury in mice.一种具有天然 IgM 抗体特异性的单链抗体构建体可减轻小鼠肝脏缺血再灌注损伤。
J Cell Mol Med. 2024 Apr;28(8):e18291. doi: 10.1111/jcmm.18291.
9
Engineered IgM and IgG cleaving enzymes for mitigating antibody neutralization and complement activation in AAV gene transfer.用于减轻 AAV 基因转移中抗体中和和补体激活的工程 IgM 和 IgG 裂解酶。
Mol Ther. 2024 Jul 3;32(7):2080-2093. doi: 10.1016/j.ymthe.2024.05.004. Epub 2024 May 7.
10
IgM contributes to glomerular injury in FSGS.IgM 有助于 FSGS 的肾小球损伤。
J Am Soc Nephrol. 2013 Feb;24(3):393-406. doi: 10.1681/ASN.2012020187. Epub 2013 Feb 7.
本文引用的文献
1
Clinical Significance of Immune Deposits and Complement System Activation in FSGS: Findings from the Cure Glomerulonephropathy Network Study.局灶节段性肾小球硬化中免疫沉积物和补体系统激活的临床意义：肾小球肾炎治愈网络研究的结果
Kidney360. 2025 Apr 1;6(8):1384-1393. doi: 10.34067/KID.0000000787.
2
Combined Rituximab and Daratumumab Treatment in Difficult-to-Treat Nephrotic Syndrome Cases.利妥昔单抗与达雷妥尤单抗联合治疗难治性肾病综合征病例
Kidney Int Rep. 2024 Apr 4;9(6):1892-1896. doi: 10.1016/j.ekir.2024.04.006. eCollection 2024 Jun.
3
Urinary complement biomarkers in immune-mediated kidney diseases.免疫介导性肾脏疾病中的尿液补体生物标志物。
Front Immunol. 2024 Jun 3;15:1357869. doi: 10.3389/fimmu.2024.1357869. eCollection 2024.
4
Glomerular capillary C3 deposition as a risk factor for unfavorable renal outcome in pediatric primary focal segmental glomerular sclerosis.肾小球毛细血管C3沉积作为儿童原发性局灶节段性肾小球硬化症不良肾脏预后的危险因素。
Front Pediatr. 2023 Mar 21;11:1137375. doi: 10.3389/fped.2023.1137375. eCollection 2023.
5
Refractory Minimal Change Disease and Focal Segmental Glomerular Sclerosis Treated With Anakinra.用阿那白滞素治疗难治性微小病变肾病和局灶节段性肾小球硬化症。
Kidney Int Rep. 2021 Oct 30;7(1):121-124. doi: 10.1016/j.ekir.2021.10.018. eCollection 2022 Jan.
6
Natural antibody and complement activation characterize patients with idiopathic nephrotic syndrome.天然抗体和补体激活可作为特发性肾病综合征的特征。
Am J Physiol Renal Physiol. 2021 Oct 1;321(4):F505-F516. doi: 10.1152/ajprenal.00041.2021. Epub 2021 Aug 30.
7
Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosis.衰变加速因子的缺失会导致足细胞损伤和肾小球硬化。
J Exp Med. 2020 Sep 7;217(9). doi: 10.1084/jem.20191699.
8
Co-Deposition of IgM and C3 May Indicate Unfavorable Renal Outcomes in Adult Patients with Primary Focal Segmental Glomerulosclerosis.IgM 和 C3 共同沉积可能预示原发性局灶节段性肾小球硬化成年患者的不良肾脏结局。
Kidney Blood Press Res. 2019;44(5):961-972. doi: 10.1159/000501827. Epub 2019 Aug 22.
9
Clinical Significance of IgM and C3 Glomerular Deposition in Primary Focal Segmental Glomerulosclerosis.原发性局灶节段性肾小球硬化中IgM和C3肾小球沉积的临床意义
Clin J Am Soc Nephrol. 2016 Sep 7;11(9):1582-1589. doi: 10.2215/CJN.01190216. Epub 2016 Jun 23.
10
Complement Activation in Patients with Focal Segmental Glomerulosclerosis.局灶节段性肾小球硬化患者的补体激活
PLoS One. 2015 Sep 3;10(9):e0136558. doi: 10.1371/journal.pone.0136558. eCollection 2015.
Zotero 插件